In CRC, LASP1 is reported to enhance tumor progression and metastatic potential through the activation of the mitogen‐activated protein kinase signaling pathway [42], Hippo signaling pathway [43], or through interaction with the CCT8 [44]. This evidence concerns the gene LASP1 and colorectal carcinoma.